Valuation: ALTEOGEN Inc.

Market Cap 17,652B 13.01B 11.49B 10.87B 9.86B 18.48B 1,249B 18.66B 130B 50.24B 638B 48.87B 47.81B 2,052B P/E 2026 *
57x
P/E 2027 * 44.3x
Enterprise Value 17.16B 12.65M 11.16M 10.56M 9.58M 17.96M 1.21B 18.14M 127M 48.83M 620M 47.5M 46.47M 1.99B EV / Sales 2026 *
35.2x
EV / Sales 2027 * 25.6x
Free-Float
74.44%
Yield 2026 *
0.17%
Yield 2027 * 0.22%
1 day+0.40%
1 week+1.60%
Current month-17.56%
1 month-20.78%
3 months-11.65%
6 months-13.50%
Current year-26.69%
1 week 244,000
Extreme 244000
260,000
1 month 244,000
Extreme 244000
329,000
Current year 194,615.38
Extreme 194615.384615
406,923.08
1 year 194,615.38
Extreme 194615.384615
437,692.31
3 years 38,615.38
Extreme 38615.384615
437,692.31
5 years 21,442.31
Extreme 21442.307691
437,692.31
10 years 2,804.49
Extreme 2804.487177
437,692.31
Manager TitleAgeSince
Chief Executive Officer 61 2025-12-25
Director of Finance/CFO 61 2023-03-27
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 70 2021-03-28
Director/Board Member 61 2023-03-27
Date Insider Type Main position Quantity % Market Cap. Importance
5/21/25 Exercice

Chief Executive Officer

7,200 0.0135%
3/27/24 Sell 1,600,000 3.0182%
1/5/24 Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
+0.40%+1.60%-29.28%+383.92% 13.01B
+3.13%+11.45%+703.24%+96.98% 81.23B
-0.23%-6.64%+33.84%-8.80% 74.94B
+1.05%+2.78%-7.05%-25.22% 60.9B
-1.07%-0.43%-10.19%+32.27% 47.22B
-0.39%-2.50%-12.21%+165.03% 44.68B
-0.71%+0.76%+63.93%-11.65% 33.55B
-1.30%-2.94%+46.86%+113.26% 24.97B
+0.73%-0.32%+52.79%+94.93% 15.17B
-0.96%-4.71%+26.96%+150.17% 12.9B
Average -0.38%-0.87%+86.89%+99.09% 40.86B
Weighted average by Cap. -0.45%+0.32%+152.45%+62.14%

Financials

2026 *2027 *
Net sales 488B 360M 317M 300M 272M 510M 34.5B 515M 3.6B 1.39B 17.62B 1.35B 1.32B 56.7B 660B 487M 430M 406M 369M 691M 46.7B 698M 4.88B 1.88B 23.85B 1.83B 1.79B 76.75B
Net income 311B 229M 202M 192M 174M 326M 22.01B 329M 2.3B 886M 11.24B 861M 843M 36.17B 375B 276M 244M 231M 209M 392M 26.5B 396M 2.77B 1.07B 13.53B 1.04B 1.01B 43.55B
Net Debt -495B -365M -322M -305M -276M -518M -35B -523M -3.65B -1.41B -17.87B -1.37B -1.34B -57.52B -739B -545M -481M -455M -413M -774M -52.29B -781M -5.46B -2.1B -26.7B -2.05B -2B -85.93B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
181
Date Price Change Volume
26-09-29 ₩253,500.00 +0.40% 297,353
26-09-28 ₩252,500.00 +1.00% 270,647
26-09-23 ₩250,000.00 +0.20% 222,524
26-09-22 ₩249,500.00 -2.16% 276,847
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
253,500.00KRW
Average target price
405,512.82KRW
Spread / Average Target
+59.97%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock